Radiology AI deployment monitoring is the structured process of watching an algorithm's technical and clinical behavior after it enters routine workflow. It answers a specific question: is the model still performing as expected on the current patient population, equipment, and data pipeline? The ACR–SIIM practice parameter defines deployment as introducing an AI solution into clinical workflow for patient care, and describes drift as gradual degradation in model performance over time [1]. Monitoring therefore requires more than a one-time local acceptance test. It needs assigned roles, defined data sources, statistical methods, and a response plan when signals deviate. This article explains the named workflow, technical decision points, evidence limitations, and a concrete evaluation example drawn from current primary documents.
Defining the Monitoring Workflow and Oversight Roles
A monitoring program begins with role assignment. The ACR–SIIM practice parameter identifies informaticists and IT professionals as responsible for configuring infrastructure, ensuring security and privacy, and maintaining technical systems needed for post-deployment monitoring, including integration with registries [1]. Data scientists can assist in designing statistically sound local validation protocols, including determining exam volumes and types, develop automated data pipelines, and synthesize feedback into findings that inform governance and quality assurance processes locally and in national registries [1]. Radiologists and other qualified end-users interpret AI-derived outputs and provide the clinical comparator that monitoring depends on.
The multi-society statement from ACR, CAR, ESR, RANZCR, and RSNA adds that a local AI oversight group should determine what sufficient monitoring looks like for a particular algorithm on a case-by-case basis [2]. This group must decide monitoring frequency, data elements, and thresholds for action. The statement notes that monitoring strategies are not standardized and can range from real-time continuous monitoring to periodic review depending on model risk and patient safety implications [2]. Notification protocols should also ensure qualified end-users know when AI solutions are being used contemporaneously within their scope of work [1].
Technical Decision Points: Data Orchestration and Monitoring Frequency
Monitoring depends on reliable data routing. The multi-society statement explains that DICOM and HL7 data orchestration must ensure the right slices from the correct series of the relevant study for the right patient in the right setting are sent to the appropriate AI in an optimized time [2]. Understanding and structuring data content is essential for dependable orchestration [2]. A Mayo Clinic team describes a workflow orchestrator called DEWEY that listens for new DICOM studies, classifies them by tags, launches tag-specific workflows, monitors completion, and wraps AI outputs into DICOM objects routed back to PACS or other systems [3].
Monitoring frequency is a second decision point. The Mayo Clinic framework performs daily monitoring with automated and human-in-the-loop components. Splunk provides automated alerts for technical failures or high memory usage, while ServiceNow tickets support human review [3]. Weekly monitoring identifies trends that are hard to detect from daily checks, covering utilization, failures, and data drift through Tableau dashboards and Python scripts [3]. This layered cadence separates immediate technical failures from slower performance degradation that requires trend analysis.
A Suggested Local Monitoring Plan for a Triage Algorithm
A practice deploying a pulmonary embolism triage algorithm could structure monitoring in three layers. First, daily automated checks would track run counts, technical failures, and output latency through an orchestration log, with alerts sent to IT staff for events such as high memory usage [3]. Second, weekly dashboards would plot concordance between AI flags and radiologist report findings, using the report as a surrogate for ground truth [2]. Third, monthly review would compare local concordance to Assess-AI national benchmarks for pulmonary embolism and open discordant cases in the Forensics App for root-cause analysis [5].
This plan is a suggestion, not a validated protocol. The practice would need to define its own thresholds for action and determine whether the radiologist report is a sufficiently strong comparator for this use case. The multi-society statement cautions that the strength of opportunistic labeling may differ from initial validation labeling [2]. The local oversight group should also decide whether to monitor input metadata such as scanner manufacturer and protocol, since deviation from manufacturer specifications can result in degraded performance [2].
Surrogate Labels and the Limits of Real-Time Accuracy
Real-time sensitivity, specificity, and positive predictive value cannot be calculated during continuous monitoring because ground truth is not immediately available [2]. The multi-society statement proposes using the interpreting radiologist's final report as a surrogate for model accuracy where possible [2]. This contemporaneous radiologist interpretation is considered a surrogate for ground truth, but the strength of this opportunistic labeling may differ from labeling provided during initial validation studies [2]. Monitoring should also harvest metadata including equipment manufacturer, protocol used, radiation dose, and patient demographics [2].
ACR's Assess-AI registry formalizes this approach. It uses large language models to extract structured findings from unstructured radiology report text, enabling surrogate ground truth extraction at scale [4]. ACR terms these LLM-extracted findings "surrogate ground truth" rather than ground truth to reflect that findings are inferred with LLMs and not annotated by a radiologist [4]. ACR acknowledges that LLMs can be prone to hallucinations and overconfidence, and states it takes precautions such as rigorous prompt development, testing, and model selection as well as ongoing performance monitoring [4].
Registry Benchmarking and Local Forensic Review
Assess-AI is a quality assurance registry under ACR's National Radiology Data Registry that provides real-world monitoring of AI algorithms deployed in clinical workflow [4]. It compares a site's locally deployed AI algorithm performance to national benchmarks and facilities with similar characteristics such as region and facility type [4]. Participating sites submit image study metadata, AI results, patient demographics, and radiology report text [4]. The registry currently supports use cases including intracranial hemorrhage, pulmonary embolism, pneumothorax, large vessel occlusion, bone age, and cervical spine fracture [5].
Facilities can investigate discordant cases locally using the Forensics App, completing a review loop that supports root-cause analysis and AI governance [5]. The registry delivers concordance and discordance rates between AI results and radiology reports, comparisons to national benchmarks, and comparisons to similar facilities [4]. Only the imaging study date is required as protected health information; no other PHI is needed for submission [4]. This design allows benchmarking without moving identifiable patient data offsite.
Drift Detection Without Immediate Ground Truth
A RadioGraphics review proposes a monitoring system based on two families of data points that do not require immediate determination of ground truth: temporal stability of inputs and outputs, and predictive divergence relative to a deployment initiation baseline [6]. The authors add uncertainty quantification as a third element to help prioritize reviews when labels are delayed or not continually feasible [6]. Threshold-based alerting is paired with tiered escalation mechanisms and root cause analysis to distinguish degradation of the AI algorithm from data or integration pipeline issues [6].
The review describes a concrete example: predictive divergence using Jensen-Shannon divergence with weekly rolling divergence scores for studies from a single scanner. A software update in week 6 preceded a threshold breach in week 7, prompting a root cause analysis and a scoped rollback during week 8. The triaging AI algorithm was paused while errors were fixed in preprocessing. After retesting, the algorithm was reinstated with divergence scores reverting to normal in week 10 [6]. This example shows how monitoring can catch integration problems rather than model degradation alone.
Sources & references
- acr–siim practice parameter for imaging artificial intelligence (ai) · gravitas.acr.org
- Developing, Purchasing, Implementing and Monitoring AI Tools in Radiology: Practical Considerations. A Multi-Society Statement From the ACR, CAR, ESR, RANZCR & RSNA - Journal of the American College of Radiology · www.jacr.org
- State of the AI: Post-Deployment Monitoring of Radiology-Focused Internally Developed AI - ScienceDirect · www.sciencedirect.com
- Assess-AI FAQs : NRDR - National Radiology Data Registry Support · nrdrsupport.acr.org
- ACR’s Assess-AI: A Registry for Real-World Performance Monitoring of Clinical Imaging AI - Journal of the American College of Radiology · www.jacr.org
- Postdeployment Monitoring and Surveillance Methods, Guidelines, and Possibilities for AI in Radiology | RadioGraphics · pubs.rsna.org
- Developing, Purchasing, Implementing and Monitoring AI Tools in Radiology: Practical Considerations. A Multi-Society Statement from the ACR, CAR, ESR, RANZCR and RSNA | Radiology: Artificial Intelligence · pubs.rsna.org
- Postdeployment Monitoring and Surveillance Methods, Guidelines, and Possibilities for AI in Radiology | RadioGraphics · pubs.rsna.org